PRI's Focus on Health Care
View this email in your browser ([link removed])
[link removed]
Sally Pipes Discusses Prescription Drugs and Inflation Reduction Act on Eric Bolling: The Balance
TV | Sally Pipes
September 20, 2022
Watch PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy discuss prescription drug costs and the so-called Inflation Reduction Act on “Eric Bolling: The Balance” on Newsmax TV.
Read more. . . ([link removed])
The FDA tasks the Reagan-Udall Foundation with a whitewash review
Washington Examiner | Henry Miller & Jeff Stier
September 17, 2022
The Food and Drug Administration ([link removed]) has problems in many of the product areas it oversees. These include the slow approval of drugs, unnecessary and prolonged shortages of infant formula, and the problematic, ineffective regulation of tobacco products. To his credit, FDA Commissioner Dr. Robert Califf seems to realize his agency has issues.
Read more. . . ([link removed])
In Political Speech, "Universal" Means Anything But
Right by the Bay | McKenzie Richards
September 21, 2022
Every few months, the argument to “universalize” some sector of the economy captures national attention – be it for universal health care, universal childcare, or universal student loan forgiveness. All the arguments have an all-too-often overlooked fatal flaw: they assume goods are not scarce.
In economic terms, all goods have a limit to them which makes universality impossible. Thus, a term like “universal health care” is quite literally too good to be true.
Read more . . . ([link removed])
Workers Want Greater Control of Their Healthcare Dollars
Newsmax | Sally Pipes
September 15, 2022
The share of workers enrolled in a high-deductible health plan increased substantially last year, according to new research ([link removed]) from the State Health Access Data Assistance Center at the University of Minnesota.
About 56% of people with employer-sponsored coverage had high-deductible plans in 2021. That’s 5.3 percentage points more than in 2020.
Read more. . . ([link removed])
============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2022 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
P.O. Box 60485 | Pasadena, CA 91116
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.